Keyphrases
Acute Promyelocytic Leukemia
100%
Acute Promyelocytic Leukemia Cells
11%
All-trans Retinoic Acid
11%
Annexin
11%
Anticoagulant Activity
11%
Anticoagulants
11%
Bleeding
33%
Cancer Procoagulant
11%
Cell-derived
11%
Cellular Expression
11%
Clot
22%
Coagulant
11%
Coagulation
11%
Coagulation Dysfunction
100%
Coagulation Factors
11%
Coagulopathy
66%
Complete Remission
11%
Complex Interactions
11%
Conventional Chemotherapy
22%
Current Treatment
11%
Disseminated Intravascular Coagulation
22%
Elastase
11%
Endothelial Cells
22%
Enzymatic Activation
11%
Fibrinogenolysis
11%
Fibrinolysis
55%
Hemorrhagic Complications
11%
High Risk
11%
Human Tissue
11%
Induction Chemotherapy
11%
Inflammatory Cells
11%
Interleukin-1β
11%
Leukemia
11%
Leukemic Cells
33%
Leukocytes
11%
Life-threatening
11%
Oncology
22%
Pathophysiologic Processes
11%
Permeability Factor
11%
Phospholipids
11%
Plasmin Inhibitors
11%
Plasminogen Activator inhibitor-1 (PAI-1)
11%
Profibrinolytic
33%
Promyelocytes
22%
Protease
11%
Proteolytic Cascade
11%
Rapid Resolution
11%
Rapidly Evolving
11%
Terminal Differentiation
11%
Thrombin
11%
Thrombin Generation
11%
Thrombomodulin
11%
Thrombotic Complications
11%
Tissue Factor
33%
Tissue Plasminogen Activator (t-PA)
22%
Trans-retinoic Acid
44%
Tumor Necrosis Factor-α
22%
U-PA
11%
Urokinase
11%
Vascular Permeability
11%
Medicine and Dentistry
Acute Promyelocytic Leukemia
100%
Alpha 2-Antiplasmin
10%
Anticoagulation
10%
Antithrombotic
10%
Bleeding
20%
Blood Clotting Factor
10%
Cancer Procoagulant
10%
Chemotherapy
20%
Coagulopathy
60%
Cytokine
10%
Diseases
20%
Disseminated Intravascular Coagulation
20%
down Regulation
10%
Elastase
10%
Endothelial Cell
20%
Fibrinogenolysis
10%
Fibrinolysis
50%
Human Tissue
10%
Induction Chemotherapy
10%
Inflammatory Cell
10%
Interleukin 1
10%
Leukemia Cell
10%
Leukocyte
10%
Lipocortin
10%
Mediator
20%
Oncology
20%
Phospholipid
10%
Plasminogen Activator Inhibitor
10%
Procoagulant
60%
Promyelocyte
20%
Proteinase
10%
Thrombin
20%
Thrombomodulin
10%
Thromboplastin
30%
Tissue Plasminogen Activator
10%
Tretinoin
50%
Tumor Necrosis Factor
30%
Upregulation
10%
Urokinase
10%
Vasculotropin
10%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha 2 Antiplasmin
10%
Anticoagulant Activity
10%
Anticoagulant Agent
10%
Bleeding
20%
Blood Clotting Disorder
60%
Blood Clotting Factor
10%
Cancer Procoagulant
10%
Chemotherapy
30%
Cytokine
10%
Disease
20%
Disseminated Intravascular Clotting
20%
Elastase
10%
Interleukin 1
10%
Lipocortin
10%
Phospholipid
10%
Plasminogen Activator Inhibitor
10%
Procoagulant
60%
Promyelocytic Leukemia
100%
Proteinase
10%
Remission
10%
Retinoic Acid
50%
Thrombin
20%
Thrombomodulin
10%
Thromboplastin
30%
Tissue Plasminogen Activator
10%
Tumor Necrosis Factor
30%
Urokinase
10%
Vasculotropin
10%